Spexis Ltd. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of respiratory therapeutics. The firm focuses on rare, chronic respiratory diseases (CRD) and chronic lung infections in cystic fibrosis. Its product pipeline includes ColiFin, Inhaled Murepavadin, Balixafortide (POL6326), OMPTA, EBX-002, and POL6014 (Lonodelestat). The company was founded by Daniel Obrecht and Jean-Pierre Obrecht in 1996 and is headquartered in Allschwil, Switzerland.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Aridis Pharmaceuticals discovers and develops anti-infectives to be used as add-on treatments to standard-of-care antibiotics. The company is utilizing its proprietary ʎPEXTM and MabIgX technology platforms to rapidly identify rare, potent antibody-producing B-cells from patients who have successfully overcome infection and to rapidly manufacture monoclonal antibodies (mAbs) for the therapeutic treatment of critical infections. These mAbs are already of human origin and functionally optimized for high potency by the donor's immune system; hence, they technically do not require genetic engineering or further optimization to achieve full functionality.

ABAC Therapeutics is aimed at seeking first-in-class drugs for precision treatment of MDR Gram-negative infections. While potent pathogen-specific antibacterial activity is essential, we believe that it is necessary to incorporate early other pharmaceutical properties, such as suitable pharmacokinetics and toxicological characteristics, to maximize the chance of success in clinical development.

Vaxdyn SL discovers and develops antigens. Its products include pipeline, clinical need and R&D programs. The company was founded by Jeronimo Pachon, Pilar Perez-Romero and Michael J. McConnell in 2011 and is headquartered in Seville, Spain.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

KBSI conducts research support and joint research using advanced research facilities and equipment.

Evaxion Biotech A/S is a clinical-stage AI-immunology™ platform company decoding the human immune system to discover and develop novel immunotherapies to treat cancer and infectious diseases. Based on its proprietary and scalable AI-immunology core technology, Evaxion is developing a broad pipeline of novel product candidates which currently includes three patient-specific cancer immunotherapies, two of which are in Phase I/IIa clinical development. In addition, Evaxion is advancing a portfolio of vaccines to prevent bacterial and viral infections with one program currently in preclinical development against S. aureus (including Methicillin-resistant S. aureus) induced skin and soft tissue infections.

Zavante is a clinical-stage biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients.

The United States Department of Veterans Affairs (VA) is a federal Cabinet-level agency that provides near-comprehensive healthcare services to eligible military veterans at VA medical centers and outpatient clinics located throughout the country; several non-healthcare benefits including disability compensation, vocational rehabilitation, education assistance, home loans, and life insurance; and provides burial and memorial benefits to eligible veterans and family members at 135 national cemeteries.

Guangzhou Xinchuangyi Drug Clinical Research Co., Ltd., established on 2019-01-16, Business scope includes drug research and development;Pharmaceutical Research Services;Medical Research and Experimental Development;Natural science research and experimental development;Human Science Research,to develop;Health Sciences Program Research,to develop;Information Technology Consulting Services;

Hebei Shenwei Pharmaceutical Co., Ltd., established on 2003-12-30, Business scope includes production and sales of small volume injections,large volume injection.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Xiangbei Welman Pharmaceutical Co., Ltd. is a holding company that manufactures pharmaceutical products. It develops antibiotic medicines in injection and tablet forms. The company was founded in 1996, and is headquartered in Liuyang, China.

Shenzhen Xintai Pharmaceutical Co., Ltd., established on 2004-01-05, Business scope includes general business items:,The licensing program is:Chinese patent medicine,Chemical API,Chemicals,Antibiotic API,antibiotic preparation,Wholesale of biochemical drugs;Three types of medical hygiene materials and dressings,Medical Suture Materials and Adhesives,Medical polymer materials and products(one-time blood transfusion,Except for infusion equipment),Class II general diagnostic equipment,Medical electronic equipment,Physiotherapy and Rehabilitation Equipment,Sales of Chinese medicine equipment;Import and export of goods and technology(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating);Chinese patent medicine,Chemical API,Chemicals,Antibiotic API,antibiotic preparation,biochemical drug,Biological product(In addition to vaccines)research and development(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating).pharmaceutical production;pharmaceutical production(Steamed Chinese Herbal Pieces,saute,broil,The application of calcining and other processing technologies and the production of secret prescription products of Chinese patent medicines).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Shenwei Pharmaceutical Group Co., Ltd., established on 2003-12-30, The business scope includes the production of Chinese patent medicines.Chinese patent medicine,Chemicals,API,Healthy food,food research and development,production and sales;{The specific business scope of drugs shall be in accordance with the items approved by the drug production license:"tablet,hard capsule,small volume injection,soft capsule,pill(Concentrated pills),Dropping pills,mixture,oral solution,Chinese medicine formula granules,API,Granules(Contains cephalosporins)"Scope operation;and items approved by the food production license:"drinks,Healthy food".}Chinese herbal medicine planting,buy,processing,Sales;Production of Chinese Herbal Pieces,Sales;Plant extracts,Research and development of Chinese herbal extracts,Production,Sales;Technology research and development of daily disinfection products,Production,Sales;Technology R&D of Cosmetics,Production,Sales;Self-operated and agent import and export business of various commodities and technologies(Except for those prohibited and restricted by the state,Commodities involving quota license management,According to the relevant regulations of the country).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (doing business as Chia Tai-Tianqing Pharmaceutical Co Ltd) is a company headquartered in Lianyungang, China. The firm manufactures pharmaceutical products. It was founded in 1969. Kang Xin Yu is the current CEO of the firm.

Chongqing Rongji Environmental Protection Engineering Co., Ltd., established on 2011-03-09, Business scope includes general items:engage in construction related business(Practicing with relevant qualification certificates);Research and development of environmental protection equipment;Green facilities,electrical appliance,Design of Automatic Control System,Sales,Install,Commissioning and technical consulting services(Installation and maintenance of gas burning appliances not included);sewage treatment;Research and development of biological additives for sewage treatment,Production,Sales(Free of hazardous chemicals and drugs);Inspection and testing service(After obtaining the relevant administrative license,Engage in business activities within the scope of the license);Sales of sewage treatment chemicals(Free of Hazardous Chemicals).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)